A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This is a 2-part, double-blind, randomized, placebo-controlled, first-in-human trial evaluating a single ascending dose (4-way crossover, Part A) and multiple ascending doses (Part B) of CVL-354.
Epistemonikos ID: 5ec07b266bbd572d5c33418af6550474bf76ccb7
First added on: Oct 02, 2023